Mass screening to reduce premature cardiovascular mortality by 25% by 2035: this is the purpose of …
Diabetes
-
-
A new research study provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe …
-
The cholesterol-lowering therapy evolocumab reduced the risk of major adverse cardiac events by nearly one-third among …
-
GLP-1s, a class of drugs used to treat type 2 diabetes, obesity, cardiovascular disease, and other …
-
A new study by UCLA Health published in Cell presents a major advancement in the future …
-
Berries such as strawberries, which are rich in various nutrients and antioxidants, are considered good foods …
-
The winner of the women’s group talent show’s obesity turned out to be caused by polycystic …
-
He Model Center for Diabetes, Obesity and Nutrition (CEMDON) It is positioned as an innovative proposal …
-
Semaglutide, a common ingredient in GLP-1 weight-loss medications, is associated with lower risks of worsening mental …
-
The 67-year-old Man Tsz-leung won the 25th Golden Horse Award for Best Actor for “Big Head …
